DALACIN C

Medicinal product

(Invented) name

DALACIN C

Active substance (s)

Klindamicinas

Strength

300 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G01AA10, Clindamycin

Marketing authorisation holder

UAB Tojaris projektai, Lietuva

Date of authorisation

2024-11-28

Date of renewal

Documents

2251_Dalacin C_N16_PL.docx

2251_Dalacin C_N16_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Klindamicinas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
115902	102007	1102007	lizdinė plokštelė	N16		Receptinis	LT/L/24/2251/001	Netiekiama	-	2024-12-30	No	-	-	Download

Stadijos

Data	Stadija
2024-11-28	Registruotas